What's new

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 67, Status: Authorised

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 67, Status: Authorised

Jun 2, 2025 - 16:20
 0
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 67, Status: Authorised
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 67, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Camzyos, mavacamten, D...

Next Article

Human medicines European public assessment report (EPAR): Tecartus, brexucabtage...

Related Posts

Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0

Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0